Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Total Liabilities (2024 - 2026)

Updated

Radiopharm Theranostics' Total Liabilities came in at $268,206 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 4.0% from $279,293 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Radiopharm Theranostics' Total Liabilities was $256,790, down 99.4% from FY2025.

  • Going back by fiscal year, Total Liabilities was $43.61 million in FY2025 and $294,472 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 115.90 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 152.26 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 68.11 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 38.37 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 115.70 Bn
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - 37.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.81 Mn
Jun 30, 2025 43.61 Mn
Dec 31, 2024 40.45 Mn
Jun 30, 2024 44.68 Mn
API Access

Radiopharm Theranostics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=RADX&period=max&api_key=YOUR_API_KEY